Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.
Sugden BM, Grimm SE, Wolff R, Armstrong N, Otten T, Abu-Zahra T, Perry M, Patel M, Chen J, Noake C, Joore M, Witlox WJA. Sugden BM, et al. Among authors: witlox wja. Pharmacoeconomics. 2024 Jun;42(6):615-618. doi: 10.1007/s40273-024-01381-z. Epub 2024 May 7. Pharmacoeconomics. 2024. PMID: 38713424 Free PMC article. No abstract available.
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer.
Witlox WJA, Ramaekers BLT, Lacas B, Le Pechoux C, Sun A, Wang SY, Hu C, Redman M, van der Noort V, Li N, Guckenberger M, van Tinteren H, Hendriks LEL, Groen HJM, Joore MA, De Ruysscher DKM. Witlox WJA, et al. Radiother Oncol. 2022 May;170:95-101. doi: 10.1016/j.radonc.2022.02.036. Epub 2022 Mar 5. Radiother Oncol. 2022. PMID: 35259416 Free article. Clinical Trial.
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.
Witlox WJA, Ramaekers BLT, Lacas B, Pechoux CL, Sun A, Wang SY, Hu C, Redman M, van der Noort V, Li N, Guckenberger M, van Tinteren H, Groen HJM, Joore MA, De Ruysscher DKM. Witlox WJA, et al. Radiother Oncol. 2021 Nov;164:163-166. doi: 10.1016/j.radonc.2021.09.029. Epub 2021 Oct 4. Radiother Oncol. 2021. PMID: 34619235 Free article.
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.
Witlox WJA, Ramaekers BLT, Lacas B, Le Pechoux C, Pignon JP, Sun A, Wang SY, Hu C, Redman M, van der Noort V, Li N, Guckenberger M, van Tinteren H, Groen HJM, Joore MA, De Ruysscher DKM. Witlox WJA, et al. Radiother Oncol. 2021 May;158:40-47. doi: 10.1016/j.radonc.2021.02.002. Epub 2021 Feb 13. Radiother Oncol. 2021. PMID: 33587968 Free article.
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA, Grimm SE, Riemsma R, Armstrong N, Ryder S, Duffy S, Carrera VH, Posadzki P, Worthy G, Pouwels XGLV, Ramaekers BLT, Kleijnen J, Joore MA, van Asselt ADI. Witlox WJA, et al. Pharmacoeconomics. 2021 Feb;39(2):171-180. doi: 10.1007/s40273-020-00971-x. Epub 2020 Nov 4. Pharmacoeconomics. 2021. PMID: 33145711 Free PMC article. Review.
Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants Study.
Jochems SHJ, Reulen RC, van Osch FHM, Witlox WJA, Goossens ME, Brinkman M, Giles GG, Milne RL, van den Brandt PA, White E, Weiderpass E, Huybrechts I, Hémon B, Agudo A, Bueno-de-Mesquita B, Cheng KK, van Schooten FJ, Bryan RT, Wesselius A, Zeegers MP. Jochems SHJ, et al. Among authors: witlox wja. Int J Cancer. 2020 Oct 15;147(8):2091-2100. doi: 10.1002/ijc.33008. Epub 2020 Apr 28. Int J Cancer. 2020. PMID: 32285440 Free article.
Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA, van Asselt ADI, Wolff R, Armstrong N, Worthy G, Chalker A, Buksnys T, Stirk L, Kleijnen J, Joore MA, Grimm SE. Witlox WJA, et al. Pharmacoeconomics. 2020 Apr;38(4):317-324. doi: 10.1007/s40273-019-00870-w. Pharmacoeconomics. 2020. PMID: 31814080 Free PMC article. Review.
14 results